Translational Cancer Research
Impact Factor & Key Scientometrics

Translational Cancer Research
Overview

Impact Factor

1.241

H Index

33

Impact Factor

0.468

I. Basic Journal Info

Country

China
Journal ISSN: 2218676X, 22196803
Publisher: AME Publishing Company
History: 2012-ongoing
Journal Hompage: Link
How to Get Published:

Research Categories

Scope/Description:

Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles.

II. Science Citation Report (SCR)



Translational Cancer Research
SCR Impact Factor

Translational Cancer Research
SCR Journal Ranking

Translational Cancer Research
SCImago SJR Rank

SCImago Journal Rank (SJR indicator) is a measure of scientific influence of scholarly journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from.

0.254

Translational Cancer Research
Scopus 2-Year Impact Factor Trend

Note: impact factor data for reference only

Translational Cancer Research
Scopus 3-Year Impact Factor Trend

Note: impact factor data for reference only

Translational Cancer Research
Scopus 4-Year Impact Factor Trend

Note: impact factor data for reference only

Translational Cancer Research
Impact Factor History

2-year 3-year 4-year
  • 2022 Impact Factor
    0.809 0.788 0.767
  • 2021 Impact Factor
    0.468 0.537 0.548
  • 2020 Impact Factor
    0.717 0.625 0.606
  • 2019 Impact Factor
    0.949 0.503 0.556
  • 2018 Impact Factor
    1.07 0.449 0.477
  • 2017 Impact Factor
    1.244 0.506 0.798
  • 2016 Impact Factor
    1.306 1.587 1.514
  • 2015 Impact Factor
    1.911 1.55 1.55
  • 2014 Impact Factor
    2.183 NA NA
  • 2013 Impact Factor
    2.031 NA NA
  • 2012 Impact Factor
    0 NA NA
  • 2011 Impact Factor
    NA NA NA
  • 2010 Impact Factor
    NA NA NA
  • 2009 Impact Factor
    NA NA NA
  • 2008 Impact Factor
    NA NA NA
  • 2007 Impact Factor
    NA NA NA
  • 2006 Impact Factor
    NA NA NA
  • 2005 Impact Factor
    NA NA NA
  • 2004 Impact Factor
    NA NA NA
  • 2003 Impact Factor
    NA NA NA
  • 2002 Impact Factor
    NA NA NA
  • 2001 Impact Factor
    NA NA NA
  • 2000 Impact Factor
    NA NA NA
Note: impact factor data for reference only

HIGHEST PAID JOBS

LATEX TUTORIALS

MUST-READ BOOKS


Impact Factor

Impact factor (IF) is a scientometric factor based on the yearly average number of citations on articles published by a particular journal in the last two years. A journal impact factor is frequently used as a proxy for the relative importance of a journal within its field. Find out more: What is a good impact factor?


III. Other Science Influence Indicators

Any impact factor or scientometric indicator alone will not give you the full picture of a science journal. There are also other factors such as H-Index, Self-Citation Ratio, SJR, SNIP, etc. Researchers may also consider the practical aspect of a journal such as publication fees, acceptance rate, review speed. (Learn More)

Translational Cancer Research
H-Index

The h-index is an author-level metric that attempts to measure both the productivity and citation impact of the publications of a scientist or scholar. The index is based on the set of the scientist's most cited papers and the number of citations that they have received in other publications

33

Translational Cancer Research
H-Index History